Ezetimibe: effective and safe treatment for dyslipidaemia associated with nonalcoholic fatty liver disease. Response to: Toth PP, Davidson MH: simvastatin and ezetimibe: combination therapy for the management of dyslipidaemia. Expert Opin. Pharmacother. (2005) 6(1):131-139.
Ahmed
Mohamed H
MH
Saad
Rasheed A
RA
Osman
Meissa M
MM
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001384:Azetidines / Q000627:therapeutic use*; D004338:Drug Combinations; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy*; D000069438:Ezetimibe; D000069499:Ezetimibe, Simvastatin Drug Combination; D005234:Fatty Liver / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007333:Insulin Resistance; D019821:Simvastatin / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D001384:Azetidines; D004338:Drug Combinations; D000069499:Ezetimibe, Simvastatin Drug Combination; D019821:Simvastatin; D000069438:Ezetimibe